Bioequivalence study of a generic formulation of imatinib mesylate 400 mg filmcoated tablets versus Glivec® : a randomized open-label trial, single-dose, fasting, two-period, two-sequence crossover comparison in healthy Colombian volunteers.

← Return to Article Details

Sistema OJS 3.4.0.7 - Metabiblioteca |